Unraveling the mode of action of an obesogen: Mechanistic analysis of the model obesogen tributyltin in the 3T3-L1 cell line

Molecular and Cellular Endocrinology

Volumn 370, Issue 1-2, 2013, Pages 52-64

  Pereira Fernandes, Anna ^a   Vanparys, Caroline ^a   Hectors, Tine L M ^a   Vergauwen, Lucia ^a   Knapen, Dries ^a   Jorens, Philippe G ^a   Blust, Ronny ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

3T3 L1; In vitro cell system; Microarray; Obesogen; Tributyltin

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRIBUTYLTIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRAIN 3T3; CONTROLLED STUDY; DNA SEQUENCE; ENERGY METABOLISM; GENE EXPRESSION; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIPID METABOLISM; MICROARRAY ANALYSIS; MOLECULAR MODEL; MOUSE; NILE RED STAINING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPRODUCIBILITY; STAINING; TOXICOGENETICS; TRANSCRIPTOMICS;

3T3 CELLS; ADIPOCYTES; ADIPOKINES; ANIMALS; CELL LINE; CHOLESTEROL; ENERGY METABOLISM; ESTROGENS; GENE EXPRESSION; GLUCOCORTICOIDS; LIPID METABOLISM; MICE; OBESITY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SIGNAL TRANSDUCTION; TRIALKYLTIN COMPOUNDS; TRIGLYCERIDES; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84876351707     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.02.011     Document Type: Article

References (72)

1. Ailhaud G., Fukamizu A., Massiera F., Negrel R., Saint-Marc P., Teboul M. Angiotensinogen, angiotensin II and adipose tissue development. International Journal of Obesity 2000, 24:S33-S35.
2. Atanasov A.G., Nashev L.G., Tam S., Baker M.E., Odermatt A. Organotins disrupt the 11 beta-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids. Environmental Health Perspectives 2005, 113:1600-1606.
3. Avram M.M., Avram A.S., James W.D. Subcutaneous fat in normal and diseased states - 3. Adipogenesis: from stem cell to fat cell. Journal of the American Academy of Dermatology 2007, 56:472-492.
4. Bartlett K., Eaton S. Mitochondrial beta-oxidation. European Journal of Biochemistry 2004, 271:462-469.
5. Bowers R.R., Lane M.D. A role for bone morphogenetic protein-4 in adipocyte development. Cell Cycle 2007, 6:385-389.
6. Camirand A., Marie V., Rabelo R., Silva J.E. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle. Endocrinology 1998, 139:428-431.
7. Casals-Casas C., Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annual Review of Physiology 2011, 73:135-162.
8. Christodoulides C., Lagathu C., Sethi J.K., Vidal-Puig A. Adipogenesis and WNT signalling. Trends in Endocrinology and Metabolism 2009, 20:16-24.
9. Cooke G.M. Effect of organotins on human aromatase activity in vitro. Toxicology Letters 2002, 126:121-130.
10. Cooke P.S., Naaz A. Role of estrogens in adipocyte development and function. Experimental Biology and Medicine 2004, 229:1127-1135.
11. Danilovich N., Babu P.S., Xing W.R., Gerdes M., Krishnamurthy H., Sairam M.R. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 2000, 141:4295-4308.
12. Decherf S., Seugnet I., Fini J.B., Clerget-Froidevaux M.S., Demeneix B.A. Disruption of thyroid hormone-dependent hypothalamic set-points by environmental contaminants. Molecular and Cellular Endocrinology 2010, 323:172-182.
13. Feige J.N., Gelman L., Michalik L., Desvergne B., Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research 2006, 45:120-159.
14. Feige J.N., Gelman L., Rossi D., Zoete V., Metivier R., Tudor C., Anghel S.I., Grosdidier A., Lathion C., Engelborghs Y., Michielin O., Wahli W., Desvergne B. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. Journal of Biological Chemistry 2007, 282:19152-19166.
15. Fu M.F., Rao M., Bouras T., Wang C.G., Wu K.M., Zhang X.P., Li Z.P., Yao T.P., Pestell R.G. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. Journal of Biological Chemistry 2005, 280:16934-16941.
16. Fu Y., Luo N., Klein R.L., Garvey W.T. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. Journal of Lipid Research 2005, 46:1369-1379.
17. Gerhold D.L., Liu F., Jiang G., Li Z., Xu J., Lu M., Sachs J.R., Bagchi A., Fridman A., Holder D.J., Doebber T.W., Berger J., Elbrecht A., Moller D.E., Zhang B.B. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists. Endocrinology 2002, 143:2106-2118.
18. Gore A.C. Neuroendocrine targets of endocrine disruptors. Hormones (Athens) 2010, 9:16-27.
19. Grun F., Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006, 147:S50-S55.
20. Grun F., Blumberg B. Endocrine disrupters as obesogens. Molecular and Cellular Endocrinology 2009, 304:19-29.
21. Grun F., Watanabe H., Zamanian Z., Maeda L., Arima K., Cubacha R., Gardiner D.M., Kanno J., Iguchi T., Blumberg B. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Molecular Endocrinology 2006, 20:2141-2155.
22. Harris C.A., Haas J.T., Streeper R.S., Stone S.J., Kumari M., Yang K., Han X., Brownell N., Gross R.W., Zechner R., Farese R.V. DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes. Journal of Lipid Research 2011, 52:657-667.
23. Hassan M., El Yazidi C., Landrier J.F., Lairon D., Margotat A., Amiot M.J. Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells. Biochemical and Biophysical Research Communications 2007, 361:208-213.
24. Hectors T.L.M., Vanparys C., van der Ven K., Martens G.A., Jorens P.G., Van Gaal L.F., Covaci A., De Coen W., Blust R. Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia 2011, 54:1273-1290.
25. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:12729-12734.
26. Hill J.O., Peters J.C. Environmental contributions to the obesity epidemic. Science 1998, 280:1371-1374.
27. Hong Y.H., Hishikawa D., Miyahara H., Tsuzuki H., Nishimura Y., Gotoh C., Choi K.C., Hokari Y., Takagi Y., Lee H.G., Cho K.K., Roh S.G., Sasaki S. Up-regulation of adipogenin, an adipocyte plasma transmembrane protein, during adipogenesis. Molecular and Cellular Biochemistry 2005, 276:133-141.
28. Hu X., Feng Y., Liu X., Zhao X.F., Yu J.H., Yang Y.S., Sydow-Backman M., Horling J., Zierath J.R., Leng Y. Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake. Diabetologia 2007, 50:1048-1057.
29. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009, 4:44-57.
30. Hummasti S., Laffitte B.A., Watson M.A., Galardi C., Chao L.C., Ramamurthy L., Moore J.T., Tontonoz P. Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target. Journal of Lipid Research 2004, 45:616-625.
31. Janer G., Navarro J.C., Porte C. Exposure to TBT increases accumulation of lipids and alters fatty acid homeostasis in the ramshorn snail Marisa cornuarietis. Comparative Biochemistry and Physiology C-Toxicology & Pharmacology 2007, 146:368-374.
32. Jones M.E.E., McInnes K.J., Boon W.C., Simpson E.R. Estrogen and adiposity - utilizing models of aromatase deficiency to explore the relationship. Journal of Steroid Biochemistry and Molecular Biology 2007, 106:3-7.
33. Juvet L.K., Andresen S.M., Schuster G.U., Dalen K.T., Tobin K.A.R., Hollung K., Haugen F., Jacinto S., Ulven S.M., Bamberg K., Gustafsson J.A., Nebb H.I. On the role of liver X receptors in lipid accumulation in adipocytes. Molecular Endocrinology 2003, 17:172-182.
34. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 2006, 116:1784-1792.
35. Kannan K., Senthilkumar K., Giesy J.P. Occurrence of butyltin compounds in human blood. Environmental Science and Technology 1999, 33:1776-1779.
36. Kawashima J., Tsuruzoe K., Motoshima H., Shirakami A., Sakai K., Hirashima Y., Toyonaga T., Araki E. Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 2003, 46:231-240.
37. Kirchner S., Kieu T., Chow C., Casey S., Blumberg B. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Molecular Endocrinology 2010, 24:526-539.
38. Knapen D., Vergauwen L., Laukens K., Blust R. Best practices for hybridization design in two-colour microarray analysis. Trends in Biotechnology 2009, 27:406-414.
39. Koerner A., Kratzsch J., Kiess W. Adipocytokines: leptin - the classical, resistin - the controversical, adiponectin - the promising, and more to come. Best Practice & Research Clinical Endocrinology & Metabolism 2005, 19:525-546.
40. Li X., Ycaza J., Blumberg B. The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes. Journal of Steroid Biochemistry and Molecular Biology 2011, 127:9-15.
41. Livingstone D.E.W., Kenyon C.J., Walker B.R. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. Journal of Endocrinology 2000, 167:533-539.
42. Masuno H., Iwanami J., Kidani T., Sakayama K., Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicological Sciences 2005, 84:319-327.
43. Masuno H., Okamoto S., Iwanami J., Honda K., Shiosaka T., Kidani T., Sakayama K., Yamamoto H. Effect of 4-nonylphenol on cell proliferation and adipocyte formation in cultures of fully differentiated 3T3-L1 cells. Toxicological Sciences 2003, 75:314-320.
44. McAllister B.G., Kime D.E. Early life exposure to environmental levels of the aromatase inhibitor tributyltin causes masculinisation and irreversible sperm damage in zebrafish (Danio rerio). Aquatic Toxicology 2003, 65:309-316.
45. Meador J.P., Sommers F.C., Cooper K.A., Yanagida G. Tributyltin and the obesogen metabolic syndrome in a salmonid. Environmental Research 2011, 111:50-56.
46. Murata Y., Robertson K.M., Jones M.E.E., Simpson E.R. Effect of estrogen deficiency in the male: the ArKO mouse model. Molecular and Cellular Endocrinology 2002, 193:7-12.
47. Newbold R.R., Padilla-Banks E., Jefferson W.N., Heindel J.J. Effects of endocrine disruptors on obesity. International Journal of Andrology 2008, 31:201-208.
48. Newton B.W., Cologna S.M., Moya C., Russell D.H., Russell W.K., Jayaraman A. Proteomic analysis of 3T3-L1 adipocyte mitochondria during differentiation and enlargement. Journal of Proteome Research 2011, 10:4692-4702.
49. Ntambi J.M., Young-Cheul K. Adipocyte differentiation and gene expression. Journal of Nutrition 2000, 130:3122S-3126S.
50. Petersen R.K., Madsen L., Pedersen L.M., Hallenborg P., Hagland H., Viste K., Doskeland S.O., Kristiansen K. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Molecular and Cellular Biology 2008, 28:3804-3816.
51. Phinney D.G., Kopen G., Righter W., Webster S., Tremain N., Prockop D.J. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. Journal of Cellular Biochemistry 1999, 75:424-436.
52. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001, 29:e45.
53. Pirooznia M., Nagarajan V., Deng Y. GeneVenn - a web application for comparing gene lists using Venn diagrams. Bioinformation 2007, 1:420-422.
54. Rask E., Olsson T., Soderberg S., Andrew R., Livingstone D.E., Johnson O., Walker B.R. Tissue-specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology & Metabolism 2001, 86:1418-1421.
55. Roh S.G., Song S.H., Choi K.C., Katoh K., Wittamer V., Parmentier M., Sasaki S. Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochemical and biophysical research Communications 2007, 362:1013-1018.
56. Rosen E.D. Molecular mechanisms of adipocyte differentiation. Annales D Endocrinologie (Paris) 2002, 63:79-82.
57. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., MacDougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289(5481):950-953.
58. Saitoh M., Yanase T., Morinaga H., Tanabe M., Mu Y.M., Nishi Y., Nomura M., Okabe T., Goto K., Takayanagi R., Nawata H. Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell line KGN. Biochemical and Biophysical Research Communications 2001, 289:198-204.
59. Sargis R.M., Johnson D.N., Choudhury R.A., Brady M.J. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity 2010, 18:1283-1288.
60. Seidensticker M.J., Behrens J. Biochemical interactions in the wnt pathway. Biochimica Et Biophysica Acta-Molecular Cell Research 2000, 1495:168-182.
61. Sen A., Lea-Currie Y.R., Sujkowska D., Franklin D.M., Wilkison W.O., Halvorsen Y.D., Gimble J.M. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. Journal of Cellular Biochemistry 2001, 81:312-319.
62. Seo J.B., Moon H.M., Kim W.S., Lee Y.S., Jeong H.W., Yoo E.J., Ham J.Y., Kang H.J., Park M.G., Steffensen K.R., Stulnig T.M., Gustafsson J.A., Dai Park S., Kim J.B. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Molecular and Cellular Biology 2004, 24:3430-3444.
63. Smas C.M., Sul H.S. Control of adipocyte differentiation. Biochemical Journal 1995, 309:697-710.
64. Smyth, G.K., 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments, Stat Appl Genet Mol Biol. 3, 1-2 (Article3).
65. Supek F., Bosnjak M., Skunca N., Smuc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE 2011, 6:e21800.
66. Taxvig C., Dreisig K., Boberg J., Nellemann C., Schelde A.B., Pedersen D., Boergesen M., Mandrup S., Vinggaard A.M. Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARgamma activation. Molecular and Cellular Endocrinology 2012, 361:106-115.
67. Thayer K.A., Heindel J.J., Bucher J.R., Gallo M.A. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environmental Health Perspectives 2012, 120:779-789.
68. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
69. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004, 92:347-355.
70. Van Harmelen V., Reynisdottir S., Cianflone K., Degerman E., Hoffstedt J., Nilsell K., Sniderman A., Arner P. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. Journal of Biological Chemistry 1999, 274:18243-18251.
71. Vergauwen L., Benoot D., Blust R., Knapen D. Long-term warm or cold acclimation elicits a specific transcriptional response and affects energy metabolism in zebrafish. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2010, 157:149-157.
72. Yanik S.C., Baker A.H., Mann K.K., Schlezinger J.J. Organotins are potent activators of PPARgamma and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells. Toxicological Sciences 2011, 122:476-488.